Publications by authors named "Jan Walewski"

89Publications

PD1 distribution pattern, regardless of the cell origin, is an independent microenvironmental prognostic factor for progression-free survival in follicular lymphoma.

Pathol Res Pract 2020 Oct 29;216(10):153096. Epub 2020 Jun 29.

Pathology Laboratory, Department of Pathology and Laboratory Diagnostics, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland; Department of Diagnostic Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prp.2020.153096DOI Listing
October 2020

Aggressive B-cell lymphoma: chasing the target.

Authors:
Jan Walewski

J Investig Med 2020 02 30;68(2):331-334. Epub 2019 Oct 30.

Lymphoid Malignancy, Maria Sklodowska-Curie Institute - Oncology Center, Warszawa, Poland

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jim-2019-001169DOI Listing
February 2020

In memoriam: Professor Olga Mioduszewska.

Pol J Pathol 2018;69(3):207-208

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5114/pjp.2018.79539DOI Listing
January 2018

Mapping cancer research across Central and Eastern Europe, the Russian Federation and Central Asia: Implications for future national cancer control planning.

Eur J Cancer 2018 11 20;104:127-136. Epub 2018 Oct 20.

Institute of Cancer Policy, Cancer Epidemiology, Population & Global Health, School of Cancer Sciences, King's College London & Guy's & St.Thomas' NHS Trust, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2018.08.024DOI Listing
November 2018

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.

N Engl J Med 2018 01 10;378(4):331-344. Epub 2017 Dec 10.

From the University of British Columbia and the Department of Medical Oncology, British Columbia Cancer Agency Centre for Lymphoid Cancer, Vancouver, Canada (J.M.C., K.J.S.); the Department of Hematology, Jagiellonian University, Krakow (W.J.), the Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw (E.L.-M.), the Department of Hematology and Transfusion Medicine, Center of Postgraduate Medical Education, Warsaw (E.L.-M.), the Department of Experimental Hematology, Medical University of Lodz, Lodz (P.S.), and the Department of Lymphoid Malignancy, the Maria Sklodowska-Curie Memorial Institute and Oncology Center, Warsaw (J.W.) - all in Poland; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (D.J.S., A.Y.); the Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN (S.M.A.); the Division of Hematology and Oncology, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, South Korea (W.S.K.); Research Innovation and Statistics, Antoine-Lacassagne Cancer Center, Nice, France (A.G.); Petrov Research Institute of Oncology, St. Petersburg, Russia (S.A.); the Department of Hematology, Faculty of Medicine, University of Debrecen, Debrecen (Á.I.), and the Department of Hematology, National Institute of Oncology, Budapest (A.R.) - both in Hungary; the Department of Advanced Biomedical Science, Federico II University Hospital, Naples (M.P.), and the Institute of Hematology Seràgnoli, University of Bologna, Bologna (P.L.Z.) - both in Italy; the Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center, Houston (Y.O.); John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ (T.F.); the Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis (N.L.B.); the Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA (R.C.); the Department of Hematology-Oncology, Barbara Ann Karmanos Cancer Center, Detroit (R.R.); Gastrointestinal and Lymphoma Unit, The Royal Marsden NHS Foundation Trust, Sutton (D.C.), and the Department of Medical Oncology, University of Manchester and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester (J.R.) - both in the United Kingdom; the Department of Clinical Development, Seattle Genetics, Bothell, WA (N.C.J., E.S.); and Oncology Clinical Research (J.S., H.A.J., D.H.) and Global Biostatistics (R.L.), Millennium Pharmaceuticals, Cambridge, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1708984DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819601PMC
January 2018

Current Treatment of Chronic Lymphocytic Leukemia.

Curr Treat Options Oncol 2017 01;18(1)

Maria Sklodowska-Curie Memorial Institute-Centre of Oncology, ul. Wawelska 15B, 02-034, Warszawa, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-017-0448-2DOI Listing
January 2017

Lenalidomide potentiates CD4CD25Treg-related suppression of lymphoma B-cell proliferation.

Clin Exp Med 2017 May 10;17(2):193-207. Epub 2016 Mar 10.

Department of Immunology, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, 5 WK Roentgen Str., 02-781, Warsaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10238-016-0411-8DOI Listing
May 2017

Human regulatory T cells suppress proliferation of B lymphoma cells.

Leuk Lymphoma 2016 08 12;57(8):1903-20. Epub 2016 Jan 12.

a Department of Immunology , Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology , Warszawa , Poland ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1121260DOI Listing
August 2016

Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study.

J Clin Oncol 2015 Aug 22;33(23):2492-9. Epub 2015 Jun 22.

Owen A. O'Connor, Columbia University Medical Center; Steven Horwitz, Memorial Sloan Kettering Cancer Center, New York, NY; Tamás Masszi, St Istvan and St Laszlo Hospital, Budapest, Hungary; Achiel Van Hoof, General Hospital St-Jan, Brugge, Belgium; Peter Brown, Rigshospitalet; Poul Knoblauch, Topotarget, Copenhagen, Denmark; Jeannette Doorduijn, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands; Georg Hess, Johannes Gutenberg-University, Mainz, Germany; Wojciech Jurczak, Jagiellonian University, Krakow; Jan Walewski, Maria Sklodowska-Curie Memorial Institute and Oncology Centre, Warsaw, Poland; Shanta Chawla, Gajanan Bhat, Mi Rim Choi, and Lee F. Allen, Spectrum Pharmaceuticals, Irvine, CA; Kerry Savage, British Columbia Cancer Agency Centre, Vancouver, British Columbia, Canada; Francine Foss, Yale Cancer Center, New Haven, CT; and Andrei Shustov, University of Washington Medical Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.59.2782DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087312PMC
August 2015

Primary mediastinal large B-cell lymphoma.

Curr Hematol Malig Rep 2014 Sep;9(3):273-83

Department of Lymphoid Malignancies, Maria Sklodowska-Curie Institute and Oncology Centre, 5 WK Roentgen Str, 02-781, Warszawa, Poland,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11899-014-0219-0
Publisher Site
http://dx.doi.org/10.1007/s11899-014-0219-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180024PMC
September 2014

Polish Lymphoma Research Group Experience With Bexarotene in the Treatment of Cutaneous T-Cell Lymphoma.

Am J Ther 2016 May-Jun;23(3):e749-56

1Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, Gdansk, Poland; 2Department of Internal Medicine, New York Medical College, Valhalla, NY; 3Department of Propedeutic Oncology, Medical University of Gdansk, Gdansk, Poland; 4Department of Oncology, Center of Oncology of Professor Franciszek Lukaszczyk, Bydgoszcz, Poland; 5Department of Hematology, Collegium Medicum of the Jagiellonian University, Krakow, Poland; 6Department of Oncology, University of Warmia and Mazury, Olsztyn, Poland; 7Department of Hematology, Medical University of Gdansk, Gdansk, Poland; 8Department of Lymphoid Malignancies, Maria Sklodowska-Curie Institute and Oncology Center, Warsaw, Poland; 9Department of Dermatology, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland; 10Department of Dermatology, University of Warmia and Mazury, Olsztyn, Poland; 11Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000056DOI Listing
February 2017

Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network.

J Clin Oncol 2014 May 31;32(13):1338-46. Epub 2014 Mar 31.

Eva Hoster, Roswitha Forstpointner, Wolfgang Hiddemann, Martin H. Dreyling, and Michael Unterhalt, University Hospital Munich; Eva Hoster, University of Munich, Munich; Wolfram Klapper, University of Kiel; Christiane Pott, University Hospital Schleswig-Holstein, Kiel; Michael Hallek, Universität Köln, Köln; Stephan Stilgenbauer, University of Ulm, Ulm, Germany; Olivier Hermine, University Paris Descartes and Université Sorbonne Paris Cité; Catherine Thieblemont, Hôpital Saint Louis, Paris; Vincent Ribrag, Institut Gustave Roussy, Villejuif, France; Hanneke C. Kluin-Nelemans, University of Groningen, Groningen; Jeanette Doorduijn, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Jan Walewski and Michal Szymczyk, Maria Sklodowska-Curie Memorial Institute, Warsaw, Poland; Achiel van Hoof, A. Z. Sint Jan AV, Brugge, Belgium; Marek Trneny, Charles University General Hospital, Prague, Czech Republic; Christian H. Geisler, Rigshospitalet, Copenhagen, Denmark; and Francesco Di Raimondo, University of Catania, Italy.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2014/03/28/JCO.2013.52
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2013.52.2466
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.52.2466DOI Listing
May 2014

Comparision of benefits of early, delayed, and no administration of G-CSF after autologous peripheral blood stem cell transplantation in lymphoma patients.

Ann Transplant 2013 Jul 2;18:336-41. Epub 2013 Jul 2.

Hemato-Oncology Intensive Care Department, Maria Sklodowska-Curie Memorial Cancer Centre in Warsaw, Warsaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12659/AOT.883965DOI Listing
July 2013

Discriminant analysis involving serum cytokine levels and prediction of the response to therapy of patients with Hodgkin lymphoma.

Tumour Biol 2012 Oct 8;33(5):1733-8. Epub 2012 Jun 8.

Department of Tumor Markers, The Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, W.K. Roentgena 5, 02-781, Warszawa, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13277-012-0432-1DOI Listing
October 2012

Adjuvant vaccination with melanoma antigen-pulsed dendritic cells in stage III melanoma patients.

Med Oncol 2012 Dec;29(4):2966-77

Department of Immunology, Maria Sklodowska-Curie Memorial Institute and Oncology Centre, ul. Roentgena 5, 02-781 Warszawa, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-012-0168-1DOI Listing
December 2012

Serum macrophage colony-stimulating factor (M-CSF) in patients with Hodgkin lymphoma.

Med Oncol 2012 Sep 30;29(3):2143-7. Epub 2011 Jun 30.

The Maria Sklodowska-Curie Memorial Institute and Cancer Center, Warszawa, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-011-0010-1DOI Listing
September 2012

Partial trisomy 11, dup(11)(q23q13), as a defect characterizing lymphomas with Burkitt pathomorphology without MYC gene rearrangement.

Med Oncol 2011 Dec 27;28(4):1589-95. Epub 2010 Jul 27.

Cytogenetic Laboratory, Department of Lymphoprolipherative Disease, MSCM Cancer Centre and Institute, 5 W.K. Roentgen Str., 02-781, Warsaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-010-9614-0DOI Listing
December 2011

Procollagen I amino-terminal propeptide as a potential marker for multiple myeloma.

Clin Biochem 2010 Apr 4;43(6):604-8. Epub 2010 Jan 4.

Department of Tumor Markers, The Maria Sklodowska-Curie Memorial Institute and Oncology Centre ul. W.K. Roentgena 5, 02-781 Warszawa, Poland.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00099120090056
Publisher Site
http://dx.doi.org/10.1016/j.clinbiochem.2009.12.018DOI Listing
April 2010

A survey of prognostic value of serum factors in multiple myeloma patients before treatment: macrophage-colony stimulating factor (M-CSF) is a powerful predictor of survival.

Med Oncol 2011 Mar 31;28(1):194-8. Epub 2009 Dec 31.

Department of Tumor Markers, Maria Sklodowska-Curie Memorial Institute and Oncology Centre Warszawa, Warszawa, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-009-9403-9DOI Listing
March 2011

CHOP-21 for unfavorable Hodgkin's lymphoma. An exploratory study.

Med Oncol 2010 Jun 25;27(2):262-7. Epub 2009 Mar 25.

The Maria Skłodowska-Curie Memorial Institute and Cancer Centre, Warszawa, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-009-9202-3DOI Listing
June 2010

Usefulness of real-time PCR in long-term follow-up of follicular lymphoma patients.

Acta Biochim Pol 2007 9;54(1):135-42. Epub 2007 Mar 9.

Department of Molecular Biology and Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warszawa, Poland.

View Article

Download full-text PDF

Source
October 2007

Unusual cyclin D1 positive marginal zone lymphoma of mediastinum.

Med Oncol 2006 ;23(3):423-8

Department of Pathology, Centre of Oncology, Maria Skłodowska-Curie Memorial Institute, Warsaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1385/MO:23:3:423DOI Listing
January 2010

Unusual IgD+/CD38-follicular lymphoma with leukemic presentation.

Med Oncol 2006 ;23(1):131-5

Department of Pathology, Maria Sklodowska-Curie Memorial Cancer Centre, Warsaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1385/MO:23:1:131DOI Listing
June 2006

Frequent aberrations of chromosome 8 in aggressive B-cell non-Hodgkin lymphoma.

Cancer Genet Cytogenet 2005 Jan;156(2):114-21

Cytogenetic Laboratory, The Memorial M. Sklodowska-Curie Cancer Centre and Institute, Roentgen Str 5, 02-781 Warsaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergencyto.2004.04.009DOI Listing
January 2005

Developing a European network for adult ALL.

Hematol J 2004 ;5 Suppl 3:S46-52

Medical Department III, Hematology, Oncology, Rheumatology and Infectiology, J.W. Goethe University Hospital, Frankfurt, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.thj.6200422DOI Listing
November 2004